BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37841428)

  • 1. Biological insights into the role of TET2 in T cell lymphomas.
    Carty SA
    Front Oncol; 2023; 13():1199108. PubMed ID: 37841428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
    Ma H; O'Connor OA; Marchi E
    Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
    Tigu AB; Bancos A
    Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
    Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
    Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
    Ma H; O'Connor OA; Marchi E
    Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic and molecular insights in nodal T-follicular helper cell lymphomas.
    Marques-Piubelli ML; Amador C; Vega F
    Front Oncol; 2023; 13():1105651. PubMed ID: 36793612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
    Abukhiran I; Syrbu SI; Holman CJ
    Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.
    Krug A; Tari G; Saidane A; Gaulard P; Ricci JE; Lemonnier F; Verhoeyen E
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
    Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype.
    Keogh A; Lynott F; Papanicolau-Sengos A; Mohammed Nur M; Spillane A; Quinn F; ElHassadi E; Jaffe ES; Flavin R
    Hematol Rep; 2022 Nov; 14(4):335-341. PubMed ID: 36412627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.
    Muto H; Sakata-Yanagimoto M; Nagae G; Shiozawa Y; Miyake Y; Yoshida K; Enami T; Kamada Y; Kato T; Uchida K; Nanmoku T; Obara N; Suzukawa K; Sanada M; Nakamura N; Aburatani H; Ogawa S; Chiba S
    Blood Cancer J; 2014 Dec; 4(12):e264. PubMed ID: 25501021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
    Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
    Front Oncol; 2020; 10():898. PubMed ID: 32637355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.